SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after receiving FDA approval for its motion sickness drug, NEREUS, marking the first new treatment in this category in decades. The community is actively discussing the significant upside potential, fueled by this approval and upcoming PDUFA dates for other pipeline candidates, with many highlighting its potential off-label use for GLP-1 induced nausea. Traders are debating whether to hold for long-term growth driven by a diversified portfolio or capitalize on immediate short-term volatility.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is trending amid intense community debate, largely driven by ongoing price depreciation attributed to tax loss harvesting and persistent selling pressure from SPAC-related share overhang. Despite recent inclusion in the Russell 2000/3000 indexes and reported strong revenue growth in its latest quarter, sentiment remains highly polarized. Bulls view the stock as deeply undervalued with significant long-term potential from user growth and international expansion, while bears warn of continued dilution and question the company's valuation.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending due to significant community discussion surrounding an ongoing, repeatedly postponed proxy vote on share authorization, creating considerable market uncertainty. Investors are sharply divided, with many expressing frustration over potential dilution and management's communication, while others advocate for the shares as crucial for strategic acquisitions like Ask Sage and future growth. Despite current price stagnation, a core of optimism persists for the company's potential to secure substantial government contracts and leverage its AI capabilities within the defense and national security sectors.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is a top trending meme coin, fueled by an exceptionally active community passionately advocating its status as an "OG meme" originating from Rage Comics. This dedicated base is consistently building out an ecosystem with projects like RageMaker and RageGames, expressing strong conviction for substantial long-term growth and widespread recognition in the crypto space. They are frequently seen battling other meme coins for trending dominance and market attention.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amid sharp investor division, primarily driven by the recent FDA approval of Novo Nordisk's oral Wegovy pill and speculation around potential distribution partnerships for GLP-1 treatments. While many note the stock's significant drawdown and high short interest as bearish indicators, others view the current valuation as a prime long-term buying opportunity, citing strong fundamentals, institutional accumulation, and the company's expansion into new health verticals and international markets. The community is actively debating whether the current dip sets the stage for a short squeeze or further decline for the direct-to-consumer telehealth provider.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amidst growing investor frustration as the stock continues to mark new lows, fueling intense debate around its management team and the prolonged absence of a permanent CEO. The community is actively discussing the disconnect between the acclaimed vehicle technology and the company's market performance, with many questioning impending production targets and speculating on potential short squeezes or further strategic shifts.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently seeing divided community sentiment, with many anticipating a potential rebound in the new year following year-end tax loss selling. Enthusiasts are holding strong, highlighting its robust community and long-term potential, while critics dismiss it as a "shit coin" with no utility. This dynamic conversation reflects the ongoing speculation about its future trajectory within the volatile crypto market.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics Holdings is capturing market attention following a proposed business combination with Applied Digital, which would see Applied Digital's cloud GPU business spun off into ChronoScale, an AI compute platform. The potential "AI merger" is fueling fervent discussion among traders, with many anticipating a significant run due to the stock's low float, while others express concerns about potential shareholder dilution.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is at the center of investor attention with a highly anticipated regulatory decision for its Cushing's syndrome drug, relacorilant, prompting intense community debate and significant trading volume. Traders are closely watching for an approval or a potential Complete Response Letter, weighing recent sector approvals against CORT's price action and broader pipeline, including its ovarian cancer program, which fuels long-term bullish sentiment despite short-term uncertainty.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals is gaining significant attention following its substantial special cash dividend and a strategic shift towards evaluating blockchain-based assets, sparking both bullish excitement and investor debate. The community is actively discussing the stock's impressive rally, with many weighing short squeeze potential against concerns of a pump-and-dump scenario fueled by future dilution or offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harbor Capital Advisors Inc. Cuts Holdings in MiMedx Group, Inc $MDXG

Harbor Capital Advisors Inc. trimmed its position in MiMedx Group, Inc (NASDAQ:MDXG - Free Report) by 71.3% in the third quarter, according to its most recent filing with the SEC. The institutional...

MiMedx Group Reaches Deal With Regen Lab USA To Distribute RegenKit-Wound Gel In US

(RTTNews) - MiMedx Group, Inc. (MDXG) Monday said it has entered into an exclusive agreement with Regen Lab USA LLC to distribute their RegenKit-Wound Gel in the United States...

MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $10.00 at Mizuho

Mizuho decreased their target price on MiMedx Group from $12.00 to $10.00 and set an "outperform" rating for the company in a report on Wednesday...

Divisadero Street Capital Management LP Boosts Stock Position in MiMedx Group, Inc $MDXG

Divisadero Street Capital Management LP lifted its position in shares of MiMedx Group, Inc (NASDAQ:MDXG - Free Report) by 362.9% during the second quarter, according to the company in its most recent...

Trigran Investments Inc. Has $51.27 Million Holdings in MiMedx Group, Inc $MDXG

Trigran Investments Inc. grew its holdings in MiMedx Group, Inc (NASDAQ:MDXG - Free Report) by 10.4% during the second quarter, according to the company in its most recent Form 13F filing with the...

MiMedx Group (NASDAQ:MDXG) Stock Price Down 5.6% - What's Next?

MiMedx Group (NASDAQ:MDXG) Trading Down 5.6% - What's Next...

MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy?

Is it a good or bad thing when a stock experiences a golden cross technical event?

Kimberly Maersk-Moller Sells 58,300 Shares of MiMedx Group (NASDAQ:MDXG) Stock

MiMedx Group, Inc (NASDAQ:MDXG - Get Free Report) insider Kimberly Maersk-Moller sold 58,300 shares of the firm's stock in a transaction that occurred on Thursday, November 6th. The shares were sold...

FY2026 EPS Estimates for MiMedx Group Reduced by Analyst

MiMedx Group, Inc (NASDAQ:MDXG - Free Report) - Stock analysts at Northland Capmk decreased their FY2026 EPS estimates for shares of MiMedx Group in a note issued to investors on Monday, November...

Wall Street Analysts Predict a 64.86% Upside in MiMedx (MDXG): Here's  What You Should Know

The mean of analysts' price targets for MiMedx (MDXG) points to a 64.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

MDXG
Mimedx Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MDXG News

MDXGMimedx Group Inc